Victrelis
Merck revenue falls
October 28, 2014Manufacturing and Production, Sales and Marketing Frazier, Merck, Q3, Victrelis, hep C, sovaldi
Merck has posted a set of disappointing financials for the latest quarter as it cuts cost across its business to …
Gilead price lambasted by US health insurers
May 21, 2014Medical Communications, Sales and Marketing Gilead, Incivek, Victrelis, hepatitis C, sovaldi
Gilead’s new hepatitis C pill Sovaldi is coming under more pressure in the US as health insurers hit out at …
Two hepatitis C drugs win Prix Galien
September 28, 2012Medical Communications, Sales and Marketing Incivo, Janssen, MSD, Victrelis, prix galien
Two new hepatitis C drugs have been given the 2012 UK Prix Galien innovative product award as joint winners in …
Merck extends biocatalysis collaboration with Codexis
May 29, 2012Manufacturing and Production Codexis, Merck, Phil Taylor, Victrelis, manufacturing
Biocatalyst specialist Codexis has signed a three-year extension of its catalyst and process development collaboration with Merck to develop enzymes …
NICE comes out fighting against appraisal delays story
May 17, 2012Sales and Marketing Daily Mail, Dillon, NHS, NICE, Pfizer, Victrelis
NICE has criticised a report that says the watchdog has taken up to nine years to appraise certain drugs. The …
Two new hep C pills recommended by NICE
April 25, 2012Sales and Marketing Incivo, Janssen, MSD, NICE, Victrelis, hep C
NICE has given its final recommendation for two new hepatitis C pills in an expedited review. Janssen’s Incivo (telaprevir) and …
NICE recommends Incivo for hepatitis C
March 16, 2012Sales and Marketing Incivo, Janssen, NICE, Victrelis, telaprevir
NICE is recommending Janssen’s hepatitis C pill Incivo for funding on the NHS in England. The drug has bypassed the …
NICE recommends Victrelis in speedy review
March 9, 2012Sales and Marketing Incivo, Janssen, Merck, NICE, Pegasus, Victrelis
NICE is recommending Merck’s hepatitis C pill Victrelis for funding in the NHS, in an expedited review. In its final …
Merck posts strong results for 2011
February 2, 2012Sales and Marketing Frazier, Merck, Singulair, Victrelis
Foreign exchange rates and strong sales from established products helped Merck to achieve single-digit growth for 2011. The US firm …
Key product launches of 2011
December 19, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2011, Actos, Benlysta, Brilique, Eliquis, Eylea, Incivek, Jevtana, Multaq, Victrelis, Xalkori, Yervoy, Zytiga, avastin, gilenya, key products
Avastin 2011 saw a handful of high profile drugs suffer because of new safety and efficacy concerns. Chief among these …
Merck and Roche begin combination hep C trial
December 16, 2011Research and Development, Sales and Marketing Copegus, Merck, Pegasys, Roche, Victrelis
Merck and Roche have started clinical trials to investigate combinations of their hepatitis C drugs. The first trial is designed …
Gilead aims for hep C lead with Pharmasset acquisition
November 22, 2011Research and Development Gilead, HCV, Pharmasset, Victrelis, hepatitis C
Gilead Sciences is to buy Pharmasset for $11 billion in a bid to become a leader in hepatitis C treatment.The …
Boehringer hails hepatitis C candidate
November 9, 2011Sales and Marketing BI201335, Boehringer Ingelheim, HCV, Incivo, Victrelis, hepatitis C
Boehringer Ingelheim believes that one of its investigational drugs for liver disease hepatitis C (HCV) could shorten patients’ treatment time …
Core products boost Merck’s results
October 31, 2011Medical Communications, Sales and Marketing Gardasil, Merck, Victrelis
Sales of core products and favourable exchange rates have helped Merck grow its revenue in a tough environment. Worldwide sales …
J&J’s hep C drug Incivo approved in Europe
September 22, 2011Sales and Marketing Incivek, Incivo, Victrelis
J&J’s potential blockbuster hepatitis C treatment Incivo has been approved in Europe. Incivo (telaprevir) was approved in combination with peginterferon …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
